Immucell Corp (ICCC): Net Income
-$1.04M
Year ended 2025-12-31
$787.4K
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.04M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$2.16M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$5.77M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$2.49M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$78.3K | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$1.02M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$1.30M | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$2.32M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$168.1K | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $508.4K | -58.1% | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | $1.21M | n/m | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | -$167.2K | n/m | 2016-03-25, From 2014-01-01 |
| 2013-12-31 | $117.4K | +31.2% | 2016-03-25, From 2013-01-01 |
| 2012-12-31 | $89.5K | n/m | 2015-03-26, From 2012-01-01 |
| 2011-12-31 | -$409.5K | n/m | 2014-03-26, From 2011-01-01 |
| 2010-12-31 | -$384.7K | n/m | 2013-03-28, From 2010-01-01 |
| 2009-12-31 | -$216.5K | n/a | 2012-03-27, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Immucell Corp (ICCC) | 2025-12-31 | -$1.04M | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$17.26M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$412.69M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$12.78M | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $6.40M | +169.9% |
| Biomerica Inc (BMRA) | 2026-05-31 | -$3.77M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$50.22M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$23.36M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$258.76M | n/m |
Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗